STOCK TITAN

Intra-Cellular Therapies to Present at the SVB Leerink 10th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq: ITCI) has announced that Sharon Mates, Ph.D., CEO and Chairman, will present at the SVB Leerink 10th Annual Global Healthcare Conference on February 26, 2021, at 10:00 am ET. The event can be accessed live and recorded via the company's Investor Relations page. Intra-Cellular Therapies focuses on developing therapeutics for central nervous system disorders, drawing on Nobel Prize-winning research to create innovative treatments for psychiatric and neurologic diseases.

Positive
  • None.
Negative
  • None.

NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the SVB Leerink 10th Annual Global Healthcare Conference on Friday, February 26, 2021 at 10:00 am ET.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

CONTACT:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
John Grimaldi
jgrimaldi@burnsmc.com
212-213-0006


FAQ

What date is Intra-Cellular Therapies presenting at the SVB Leerink Conference?

Intra-Cellular Therapies is scheduled to present on February 26, 2021.

What time will the ITCI presentation occur at the healthcare conference?

The presentation will occur at 10:00 am ET.

Where can I access the presentation by Intra-Cellular Therapies?

The presentation can be accessed under the 'Events & Presentations' section on their website.

Who is the CEO of Intra-Cellular Therapies?

The CEO of Intra-Cellular Therapies is Sharon Mates, Ph.D.

What is the focus of Intra-Cellular Therapies?

Intra-Cellular Therapies focuses on therapeutics for central nervous system disorders.

Intra-Cellular Therapies Inc.

NASDAQ:ITCI

ITCI Rankings

ITCI Latest News

ITCI Stock Data

9.08B
101.92M
2.33%
95.99%
2.23%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
BEDMINSTER